Literature DB >> 19448546

Neuromodulation 10 years on: how widely should we use this technique in bladder dysfunction?

John F Bolton1, Simon C W Harrison.   

Abstract

PURPOSE OF REVIEW: There has been growing interest in sacral nerve stimulation in the management of both overactivity syndromes and nonobstructive voiding dysfunction. Its increased use has led to a growth in experience with this treatment and where and when it is best used. At this point, some technical aspects of the use of neuromodulation have become more standardized and the next stages of research will hopefully shed light on how to maximize the efficacy of the technique. RECENT
FINDINGS: Over the past year, there has been considerable interest and development of the use of neuromodulation in colorectal surgery and much of the literature has been in this field. Recent urological developments focus on modification of technique and attempts to identify which patients are more likely to find benefit.
SUMMARY: Neuromodulation has a role in the treatment of nonobstructed urinary retention and overactive bladder syndrome, especially when accompanied by urgency incontinence. There are a number of unanswered questions remaining, however, which will need to be addressed to maximize its benefit.

Entities:  

Mesh:

Year:  2009        PMID: 19448546     DOI: 10.1097/MOU.0b013e32832ac55e

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  7 in total

Review 1.  Sacral neuromodulation: an effective treatment for lower urinary tract symptoms in multiple sclerosis.

Authors:  Federica Puccini; Alka Bhide; Suzy Elneil; G Alessandro Digesu
Journal:  Int Urogynecol J       Date:  2015-07-09       Impact factor: 2.894

2.  Concerns regarding sacral neuromodulation as a treatment option for medical-refractory overactive bladder.

Authors:  Daniel Liberman; Luc Valiquette
Journal:  Can Urol Assoc J       Date:  2011-08       Impact factor: 1.862

Review 3.  The treatment of lower urinary tract symptoms in patients with multiple sclerosis: a systematic review.

Authors:  A Tubaro; F Puccini; C De Nunzio; G A Digesu; S Elneil; C Gobbi; V Khullar
Journal:  Curr Urol Rep       Date:  2012-10       Impact factor: 3.092

4.  [Sacral neuromodulation for refractory overactive bladder].

Authors:  Arndt van Ophoven
Journal:  Urologe A       Date:  2018-11       Impact factor: 0.639

5.  Sacral neuromodulation effects on periurethral sensation and urethral sphincter activity.

Authors:  Jonathan L Gleason; Kimberly Kenton; W Jerod Greer; Olga Ramm; Jeff M Szychowski; Tracey Wilson; Holly E Richter
Journal:  Neurourol Urodyn       Date:  2012-11-20       Impact factor: 2.696

6.  Physician Use of Sacral Neuromodulation Among Medicare Beneficiaries With Overactive Bladder and Urinary Retention.

Authors:  Anne M Suskind; J Quentin Clemens; Yun Zhang; Brent K Hollenbeck
Journal:  Urology       Date:  2015-05-27       Impact factor: 2.649

7.  Understanding the dissemination of sacral neuromodulation.

Authors:  Anne M Suskind; Rodney L Dunn; Samuel R Kaufman; John O L DeLancey; J Quentin Clemens; John T Stoffel; Brent K Hollenbeck
Journal:  Surg Innov       Date:  2013-04-16       Impact factor: 2.058

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.